Park Ha Biological Technology is trading $2.79 (+5.83%) after its 1-for-8 reverse stock split became effective on August 6, 2026.

  • Nasdaq stated that the action also changed the shares’ par value and CUSIP; split-adjusted trading was expected to begin at the market open.
  • The move appears primarily mechanical, rather than evidence of a fundamental improvement in business value.
  • No newer earnings or operational catalyst was identified; broader markets are mixed, offering no strong same-direction market catalyst.